These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2561734)
1. Clonal stimulation or inhibition of human colon carcinomas and human renal carcinomas mediated by transforming growth factor-beta 1. Fan D; Chakrabarty S; Seid C; Bell CW; Schackert H; Morikawa K; Fidler IJ Cancer Commun; 1989; 1(2):117-25. PubMed ID: 2561734 [TBL] [Abstract][Full Text] [Related]
2. Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2. Chakrabarty S; Fan D; Varani J Int J Cancer; 1990 Sep; 46(3):493-9. PubMed ID: 1697568 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta inhibits the growth of renal cell carcinoma in vitro. Gomella LG; Sargent ER; Linehan WM; Kasid A J Urol; 1989 May; 141(5):1240-4. PubMed ID: 2540353 [TBL] [Abstract][Full Text] [Related]
4. Biological effects and binding properties of transforming growth factor-beta on human oral squamous cell carcinoma cells. Ichijo H; Momose F; Miyazono K Exp Cell Res; 1990 Apr; 187(2):263-9. PubMed ID: 2156718 [TBL] [Abstract][Full Text] [Related]
5. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines. Hébert CD; Birnbaum LS Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899 [TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. Hoosein NM; McKnight MK; Levine AE; Mulder KM; Childress KE; Brattain DE; Brattain MG Exp Cell Res; 1989 Apr; 181(2):442-53. PubMed ID: 2538337 [TBL] [Abstract][Full Text] [Related]
7. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta. Chakrabarty S; Jan Y; Brattain MG; Tobon A; Varani J Cancer Res; 1989 Apr; 49(8):2112-7. PubMed ID: 2539253 [TBL] [Abstract][Full Text] [Related]
8. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532 [TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169 [TBL] [Abstract][Full Text] [Related]
10. Evidence for metastatic heterogeneity of human renal cell carcinoma. Naito S; Walker SM; von Eschenbach AC; Fidler IJ Anticancer Res; 1988; 8(6):1163-7. PubMed ID: 3218952 [TBL] [Abstract][Full Text] [Related]
11. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis. Kominsky SL; Doucet M; Brady K; Weber KL J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147 [TBL] [Abstract][Full Text] [Related]
12. Tumour progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-beta receptor expression and altered responses to these growth factors. Game SM; Stone A; Scully C; Prime SS Carcinogenesis; 1990 Jun; 11(6):965-73. PubMed ID: 2161297 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of carcinoma and melanoma cell growth by type 1 transforming growth factor beta is dependent on the presence of polyunsaturated fatty acids. Newman MJ Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5543-7. PubMed ID: 2371287 [TBL] [Abstract][Full Text] [Related]
14. Expression of TGF-alpha/EGF and TGF-beta receptors in human colon carcinoma cell lines. Murthy U; Anzano MA; Greig RG Int J Cancer; 1989 Jul; 44(1):110-5. PubMed ID: 2545633 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth. Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769 [TBL] [Abstract][Full Text] [Related]
16. TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. Wu SP; Theodorescu D; Kerbel RS; Willson JK; Mulder KM; Humphrey LE; Brattain MG J Cell Biol; 1992 Jan; 116(1):187-96. PubMed ID: 1730743 [TBL] [Abstract][Full Text] [Related]
17. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression. Hsu S; Huang F; Hafez M; Winawer S; Friedman E Cell Growth Differ; 1994 Mar; 5(3):267-75. PubMed ID: 8018559 [TBL] [Abstract][Full Text] [Related]
18. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide. Schroy P; Rifkin J; Coffey RJ; Winawer S; Friedman E Cancer Res; 1990 Jan; 50(2):261-5. PubMed ID: 2295065 [TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2. Yasumura S; Lin WC; Weidmann E; Hebda P; Whiteside TL Int J Cancer; 1994 Oct; 59(2):225-34. PubMed ID: 7523315 [TBL] [Abstract][Full Text] [Related]
20. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma. Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]